PUBLICACIÓN

C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: A non-deletional mutation or polymorphism?

ACCEDER A LA PUBLICACIÓN: Scopus

Ropero P. et al.

2020 JOURNAL OF CLINICAL PATHOLOGY

Medicine (miscellaneous) (Q1), Pathology and Forensic Medicine (Q1)

JCR: 3.411

SJR: 1.1

CITAS

2

DOI

10.1136/jclinpath-2019-206004

EID

2-s2.0-85071187680

ISSN

0021-9746

EISSN

1472-4146

AUTORES DE LA UEX

José Manuel Vagace Valero

OTRAS PUBLICACIONES DE INTERÉS

Tamaño De La Fontanela En El Recién Nacido Normal. Relación Con Parámetros Antropométricos Y Bioquímicos
Prognostic Significance Of Mutation Type And Chromosome Fragility In Fanconi Anemia
Association Between Adherence To Patient Blood Management Recommendations And Postoperative Complications In Hip And Knee Arthroplasty
Prognostic Significance Of Mutation Type And Chromosome Fragility In Fanconi Anemia
Association Between Adherence To Patient Blood Management Recommendations And Postoperative Complications In Hip And Knee Arthroplasty
Haploidentical Vs. Hla-Matched Donor Hematopoietic Stem-Cell Transplantation For Pediatric Patients With Acute Lymphoblastic Leukemia In Second Remission: A Collaborative Retrospective Study Of The Spanish Group For Bone Marrow Transplantation In Children (Getmon/geth) And The Spanish Childhood Relapsed All Board (Reallnet)
Association Between Adherence To Patient Blood Management Recommendations And Postoperative Complications In Hip And Knee Arthroplasty
Haploidentical Vs. Hla-Matched Donor Hematopoietic Stem-Cell Transplantation For Pediatric Patients With Acute Lymphoblastic Leukemia In Second Remission: A Collaborative Retrospective Study Of The Spanish Group For Bone Marrow Transplantation In Children (Getmon/geth) And The Spanish Childhood Relapsed All Board (Reallnet)
Adolescent Cancer Care: What Has Changed In Spain In The Past Decade?
Haploidentical Vs. Hla-Matched Donor Hematopoietic Stem-Cell Transplantation For Pediatric Patients With Acute Lymphoblastic Leukemia In Second Remission: A Collaborative Retrospective Study Of The Spanish Group For Bone Marrow Transplantation In Children (Getmon/geth) And The Spanish Childhood Relapsed All Board (Reallnet)
Adolescent Cancer Care: What Has Changed In Spain In The Past Decade?
Venous Thromboembolism In Pediatric Patients With Acute Lymphoblastic Leukemia Under Chemotherapy Treatment. Risk Factors And Usefulness Of Thromboprophylaxis. Results Of Lal-Sehop-Pethema-2013
Adolescent Cancer Care: What Has Changed In Spain In The Past Decade?
Venous Thromboembolism In Pediatric Patients With Acute Lymphoblastic Leukemia Under Chemotherapy Treatment. Risk Factors And Usefulness Of Thromboprophylaxis. Results Of Lal-Sehop-Pethema-2013
A New Case Of Acquired Haemophilia B In The Context Of Liver Autoimmune Disease
Venous Thromboembolism In Pediatric Patients With Acute Lymphoblastic Leukemia Under Chemotherapy Treatment. Risk Factors And Usefulness Of Thromboprophylaxis. Results Of Lal-Sehop-Pethema-2013
A New Case Of Acquired Haemophilia B In The Context Of Liver Autoimmune Disease
Phase 2 Clinical Trial Of Infusing Haploidentical K562-Mb15-41bbl–activated And Expanded Natural Killer Cells As Consolidation Therapy For Pediatric Acute Myeloblastic Leukemia
A New Case Of Acquired Haemophilia B In The Context Of Liver Autoimmune Disease
Phase 2 Clinical Trial Of Infusing Haploidentical K562-Mb15-41bbl–activated And Expanded Natural Killer Cells As Consolidation Therapy For Pediatric Acute Myeloblastic Leukemia
Measurable Residual Disease Assessed By Flow-Cytometry Is A Stable Prognostic Factor For Pediatric T-Cell Acute Lymphoblastic Leukemia In Consecutive Sehop Protocols Whereas The Impact Of Oncogenetics Depends On Treatment
Phase 2 Clinical Trial Of Infusing Haploidentical K562-Mb15-41bbl–activated And Expanded Natural Killer Cells As Consolidation Therapy For Pediatric Acute Myeloblastic Leukemia
Measurable Residual Disease Assessed By Flow-Cytometry Is A Stable Prognostic Factor For Pediatric T-Cell Acute Lymphoblastic Leukemia In Consecutive Sehop Protocols Whereas The Impact Of Oncogenetics Depends On Treatment
Study Protocol For A Phase Ii, Multicentre, Prospective, Non-Randomised Clinical Trial To Assess The Safety And Efficacy Of Infusing Allogeneic Activated And Expanded Natural Killer Cells As Consolidation Therapy For Paediatric Acute Myeloblastic Leukaemia
Measurable Residual Disease Assessed By Flow-Cytometry Is A Stable Prognostic Factor For Pediatric T-Cell Acute Lymphoblastic Leukemia In Consecutive Sehop Protocols Whereas The Impact Of Oncogenetics Depends On Treatment
Study Protocol For A Phase Ii, Multicentre, Prospective, Non-Randomised Clinical Trial To Assess The Safety And Efficacy Of Infusing Allogeneic Activated And Expanded Natural Killer Cells As Consolidation Therapy For Paediatric Acute Myeloblastic Leukaemia
Management Of Iron Deficiency In Various Clinical Conditions And The Role Of Intravenous Iron: Recommendations Of The Spanish Erythropathology Group Of The Spanish Society Of Haematology And Haemotherapy
Study Protocol For A Phase Ii, Multicentre, Prospective, Non-Randomised Clinical Trial To Assess The Safety And Efficacy Of Infusing Allogeneic Activated And Expanded Natural Killer Cells As Consolidation Therapy For Paediatric Acute Myeloblastic Leukaemia
Management Of Iron Deficiency In Various Clinical Conditions And The Role Of Intravenous Iron: Recommendations Of The Spanish Erythropathology Group Of The Spanish Society Of Haematology And Haemotherapy
Optimised Molecular Genetic Diagnostics Of Fanconi Anaemia By Whole Exome Sequencing And Functional Studies
Management Of Iron Deficiency In Various Clinical Conditions And The Role Of Intravenous Iron: Recommendations Of The Spanish Erythropathology Group Of The Spanish Society Of Haematology And Haemotherapy
Optimised Molecular Genetic Diagnostics Of Fanconi Anaemia By Whole Exome Sequencing And Functional Studies
C>a Substitution In Nt 46 Of The 3' Utr Region (The Α Complex Protected Region) Of The Alpha-1 Globin Gene: A Non-Deletional Mutation Or Polymorphism?
Optimised Molecular Genetic Diagnostics Of Fanconi Anaemia By Whole Exome Sequencing And Functional Studies
C>a Substitution In Nt 46 Of The 3' Utr Region (The Α Complex Protected Region) Of The Alpha-1 Globin Gene: A Non-Deletional Mutation Or Polymorphism?
Expanding The Clinical And Genetic Spectra Of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected And Unexpected Findings
C>a Substitution In Nt 46 Of The 3' Utr Region (The Α Complex Protected Region) Of The Alpha-1 Globin Gene: A Non-Deletional Mutation Or Polymorphism?
Expanding The Clinical And Genetic Spectra Of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected And Unexpected Findings
Burkitt-Like Lymphoma With 11q Aberration: A Germinal Center-Derived Lymphoma Genetically Unrelated To Burkitt Lymphoma
Expanding The Clinical And Genetic Spectra Of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected And Unexpected Findings
Burkitt-Like Lymphoma With 11q Aberration: A Germinal Center-Derived Lymphoma Genetically Unrelated To Burkitt Lymphoma
Recomendaciones Para El Abordaje Del Déficit De Hierro: Papel Del Hierro Intravenoso
Burkitt-Like Lymphoma With 11q Aberration: A Germinal Center-Derived Lymphoma Genetically Unrelated To Burkitt Lymphoma
Recomendaciones Para El Abordaje Del Déficit De Hierro: Papel Del Hierro Intravenoso
Effect Of Polymorphisms In Transporter Genes On Dosing, Efficacy And Toxicity Of Maintenance Therapy In Children With Acute Lymphoblastic Leukemia
Recomendaciones Para El Abordaje Del Déficit De Hierro: Papel Del Hierro Intravenoso
Effect Of Polymorphisms In Transporter Genes On Dosing, Efficacy And Toxicity Of Maintenance Therapy In Children With Acute Lymphoblastic Leukemia
Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements In Pediatric Patients With Acute Lymphoblastic Leukemia On Maintenance Therapy
Effect Of Polymorphisms In Transporter Genes On Dosing, Efficacy And Toxicity Of Maintenance Therapy In Children With Acute Lymphoblastic Leukemia
Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements In Pediatric Patients With Acute Lymphoblastic Leukemia On Maintenance Therapy
Blastic Plasmacytoid Dendritic Cell Neoplasm
Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements In Pediatric Patients With Acute Lymphoblastic Leukemia On Maintenance Therapy
Blastic Plasmacytoid Dendritic Cell Neoplasm
Etiopathological Mechanisms And Clinical Characteristics Of Hyperhemolysis Syndrome In Spanish Patients With Thalassemia
Blastic Plasmacytoid Dendritic Cell Neoplasm
Etiopathological Mechanisms And Clinical Characteristics Of Hyperhemolysis Syndrome In Spanish Patients With Thalassemia
Congenital Dyserythropoietic Anemia Associated To A Gata1 Mutation Aggravated By Pyruvate Kinase Deficiency
Etiopathological Mechanisms And Clinical Characteristics Of Hyperhemolysis Syndrome In Spanish Patients With Thalassemia
Congenital Dyserythropoietic Anemia Associated To A Gata1 Mutation Aggravated By Pyruvate Kinase Deficiency
Functional Consequences Of Transferrin Receptor-2 Mutations Causing Hereditary Hemochromatosis Type 3
Congenital Dyserythropoietic Anemia Associated To A Gata1 Mutation Aggravated By Pyruvate Kinase Deficiency
Functional Consequences Of Transferrin Receptor-2 Mutations Causing Hereditary Hemochromatosis Type 3
Clinical Relevance Of Erythrocyte Ferritin In Microcytic Anemias
Functional Consequences Of Transferrin Receptor-2 Mutations Causing Hereditary Hemochromatosis Type 3
Clinical Relevance Of Erythrocyte Ferritin In Microcytic Anemias
Thalassemia Diagnosis In A Blood Donor From A Unique Trimorphic Red Blood Cell Population Observed In The Recipient
Clinical Relevance Of Erythrocyte Ferritin In Microcytic Anemias
Thalassemia Diagnosis In A Blood Donor From A Unique Trimorphic Red Blood Cell Population Observed In The Recipient
Hyperhaemolysis Syndrome Responsive To Splenectomy In A Patient With Δβ-Thalassaemia: A Discussion On Underlying Mechanisms
Thalassemia Diagnosis In A Blood Donor From A Unique Trimorphic Red Blood Cell Population Observed In The Recipient
Hyperhaemolysis Syndrome Responsive To Splenectomy In A Patient With Δβ-Thalassaemia: A Discussion On Underlying Mechanisms
Diagnostic And Therapeutic Challenges Of Primary Autoimmune Haemolytic Anaemia In Children
Hyperhaemolysis Syndrome Responsive To Splenectomy In A Patient With Δβ-Thalassaemia: A Discussion On Underlying Mechanisms
Diagnostic And Therapeutic Challenges Of Primary Autoimmune Haemolytic Anaemia In Children
Ethylenediaminetetraacetic Acid-Dependent Pseudomacrocytosis
Diagnostic And Therapeutic Challenges Of Primary Autoimmune Haemolytic Anaemia In Children
Ethylenediaminetetraacetic Acid-Dependent Pseudomacrocytosis
Diagnostic Utility Of Hfe Variants In Spanish Patients: Association With Hla Alleles And Role In Susceptibility To Acute Lymphoblastic Leukemia
Ethylenediaminetetraacetic Acid-Dependent Pseudomacrocytosis
Diagnostic Utility Of Hfe Variants In Spanish Patients: Association With Hla Alleles And Role In Susceptibility To Acute Lymphoblastic Leukemia
Impact Of Genetic Polymorphisms On Chemotherapy Toxicity In Childhood Acute Lymphoblastic Leukemia
Diagnostic Utility Of Hfe Variants In Spanish Patients: Association With Hla Alleles And Role In Susceptibility To Acute Lymphoblastic Leukemia
Impact Of Genetic Polymorphisms On Chemotherapy Toxicity In Childhood Acute Lymphoblastic Leukemia
Central Nervous System Chemotoxicity During Treatment Of Pediatric Acute Lymphoblastic Leukemia/lymphoma
Impact Of Genetic Polymorphisms On Chemotherapy Toxicity In Childhood Acute Lymphoblastic Leukemia
Central Nervous System Chemotoxicity During Treatment Of Pediatric Acute Lymphoblastic Leukemia/lymphoma
Methotrexate-Induced Subacute Neurotoxicity In A Child With Acute Lymphoblastic Leukemia Carrying Genetic Polymorphisms Related To Folate Homeostasis
Central Nervous System Chemotoxicity During Treatment Of Pediatric Acute Lymphoblastic Leukemia/lymphoma
Methotrexate-Induced Subacute Neurotoxicity In A Child With Acute Lymphoblastic Leukemia Carrying Genetic Polymorphisms Related To Folate Homeostasis
Chronic Haemolytic Anaemia Because Of Pyruvate Kinase (Pk) Deficiency In A Child Heterozygous For Haemoglobin S And No Clinical Features Of Sickle Cell Disease
Methotrexate-Induced Subacute Neurotoxicity In A Child With Acute Lymphoblastic Leukemia Carrying Genetic Polymorphisms Related To Folate Homeostasis
Chronic Haemolytic Anaemia Because Of Pyruvate Kinase (Pk) Deficiency In A Child Heterozygous For Haemoglobin S And No Clinical Features Of Sickle Cell Disease
Retinal Toxic Reactions Following Photopheresis
Chronic Haemolytic Anaemia Because Of Pyruvate Kinase (Pk) Deficiency In A Child Heterozygous For Haemoglobin S And No Clinical Features Of Sickle Cell Disease
Retinal Toxic Reactions Following Photopheresis
Infection Caused By Fusarium Species In Non-Neutropenic Oncological Patients [4]
Retinal Toxic Reactions Following Photopheresis
Infection Caused By Fusarium Species In Non-Neutropenic Oncological Patients [4]
Resolution Of Disseminated Fusariosis In A Child With Acute Leukemia Treated With Combined Antifungal Therapy: A Case Report
Infection Caused By Fusarium Species In Non-Neutropenic Oncological Patients [4]
Resolution Of Disseminated Fusariosis In A Child With Acute Leukemia Treated With Combined Antifungal Therapy: A Case Report
Fotoféresis: Nueva Terapia Inmunomoduladora Para Enfermedades Mediadas Por Linfocitos T.
Resolution Of Disseminated Fusariosis In A Child With Acute Leukemia Treated With Combined Antifungal Therapy: A Case Report
Fotoféresis: Nueva Terapia Inmunomoduladora Para Enfermedades Mediadas Por Linfocitos T.
Photopheresis: New Immunomodulatory Therapy For T-Lymphocyte Mediated Diseases
Fotoféresis: Nueva Terapia Inmunomoduladora Para Enfermedades Mediadas Por Linfocitos T.
Photopheresis: New Immunomodulatory Therapy For T-Lymphocyte Mediated Diseases
Aplastic Anemia During Treatment With Albendazole [8]
Photopheresis: New Immunomodulatory Therapy For T-Lymphocyte Mediated Diseases
Aplastic Anemia During Treatment With Albendazole [8]
Changes In Platelet Count: A Primary Or Secondary Effect Of Rhu-Epo Therapy?
Aplastic Anemia During Treatment With Albendazole [8]
Changes In Platelet Count: A Primary Or Secondary Effect Of Rhu-Epo Therapy?
Assessment Of Iron Status By Erythrocyte Ferritin In Uremic Patients With Or Without Recombinant Human Erythropoietin Therapy
Changes In Platelet Count: A Primary Or Secondary Effect Of Rhu-Epo Therapy?
Assessment Of Iron Status By Erythrocyte Ferritin In Uremic Patients With Or Without Recombinant Human Erythropoietin Therapy
Tamaño De La Fontanela En El Recién Nacido Normal. Relación Con Parámetros Antropométricos Y Bioquímicos
Assessment Of Iron Status By Erythrocyte Ferritin In Uremic Patients With Or Without Recombinant Human Erythropoietin Therapy
Tamaño De La Fontanela En El Recién Nacido Normal. Relación Con Parámetros Antropométricos Y Bioquímicos
Prognostic Significance Of Mutation Type And Chromosome Fragility In Fanconi Anemia
WEB ACCESIBLE